medigraphic.com
SPANISH

Enfermedades Infecciosas y Microbiología

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2024, Number 3

Next >>

Enf Infec Microbiol 2024; 44 (3)

Vaccination in pregnant women promotion

Solórzano SF, Marriaga NB
Full text How to cite this article

Language: Spanish
References: 8
Page: 81-82
PDF size: 57.65 Kb.


Key words:

No keywords

Text Extraction

No abstract.


REFERENCES

  1. Omer, S.B.; Zaman, K.; Roy, E.; Arifeen, S.E.; Raqib,R.; Noory, L.; Seib, K.; Breiman, R.F.; Steinhoff, M.C.Combined effects of antenatal receipt of influenza vaccineby mothers and pneumococcal conjugate vaccinereceipt by infants: Results from a randomized, blinded,controlled trial. J. Infect. Dis. 2013; 207: 1144-1147.

  2. Zimmermann, P.; Perrett, K.P.; Messina, N.L.; Donath,S.; Ritz, N.; van der Klis, F.R.M.; Curtis, N. The effectof maternal immunization during pregnancy on infantvaccine responses. EClin. Med. 2019; 13: 21-30.

  3. Voysey, M.; Kelly, D.F.; Fanshawe, T.R.; Sadarangani,M.; O’Brien, K.L.; Perera, R.; Pollard, A.J. The influenceof maternally derived antibody and infant age atvaccination on infant vaccine responses: an individualparticipant meta-analysis. JAMA Pediatr. 2017; 171:637-646.

  4. Guidelines for Vaccinating Pregnant Women; Centersfor Disease Control and Prevention: Atlanta, GA, USA,2022. Available online:https://www.cdc.gov/vaccines/pregnancy/hcp-toolkit/guidelines.html (12 July 2024)(acceso 2 agosto 2024).

  5. https://www.gob.mx/salud/acciones-y-programas/direccion-general-de-epidemiologia-boletin-epidemiologico(acceso 2 de agosto 2024)

  6. Guzman-Holst A, Luna-Casas G, Cervantes-ApolinarMY, Huerta-Garcia GC, Juliao P, Sánchez-González G.Pertussis infant morbidity and mortality trends afteruniversal maternal immunization in Mexico: An ecologicaldatabase study with time-series analysis. Vaccine.2021; 39(16):2311-2318.

  7. Halasa, N.B.; Olson, S.M.; Staat, M.A.; Newhams,M.M.; Price, A.M.; Pannaraj, P.S.; Boom, J.A.; Sahni,L.C.; Chiotos, K.; Cameron, M.A.; et al. Maternal Vaccinationand Risk of Hospitalization for COVID-19 amongInfants. N. Engl. J. Med. 2022; 387: 109-119.

  8. Kampmann, B.; Madhi, S.A.; Munjal, I.; Simões, E.A.F.;Pahud, B.A.; Llapur, C.; Baker, J.; Pérez Marc, G.; Radley,D.; Shittu, E.; et al. Bivalent Prefusion F Vaccine inPregnancy to Prevent RSV Illness in Infants. N. Engl. J.Med. 2023; 388: 1451-1464.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Enf Infec Microbiol. 2024;44